13 hours Ago By ABMN Staff
Marshall Wace LLP lifted its holdings in shares of Rockwell Medical, Inc. ( NASDAQ:RMTI – Free Report ) by 17.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
The firm owned 596,359 shares of the company’s stock after purchasing an additional 87,685 shares during the quarter. Marshall Wace LLP owned 1.85% of Rockwell Medical worth $1,217,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of RMTI. State Street Corp raised its position in shares of Rockwell Medical by 21.5% during the third quarter.
State Street Corp now owns 95,004 shares of the company’s stock worth $377,000 after purchasing an additional 16,800 shares during the period. Jane Street Group LLC acquired a new stake in shares of Rockwell Medical during the third quarter worth about $534,000. Barclays PLC acquired a new stake in shares of Rockwell Medical during the third quarter worth about $90,000.
JPMorgan Chase & Co. raised its position in shares of Rockwell Medical by 134,397.1% during the third quarter.
JPMorgan Chase & Co. now owns 47,074 shares of the company’s stock worth $187,000 after purchasing an additional 47,039 shares during the period. Finally, Raymond James Financial Inc.
bought a new position in shares of Rockwell Medical during the fourth quarter worth about $28,000. Institutional investors and hedge funds own 23.31% of the company’s stock.
Rockwell Medical Stock Down 2.7 % NASDAQ:RMTI opened at $1.10 on Wednesday.
The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.
41. The company has a market cap of $37.59 million, a PE ratio of -22.
00 and a beta of 1.62. Rockwell Medical, Inc.
has a 52-week low of $0.86 and a 52-week high of $5.15.
The stock has a 50-day simple moving average of $1.32 and a 200 day simple moving average of $2.09.
Insider Buying and Selling at Rockwell Medical In other Rockwell Medical news, major shareholder Larson Family Inve Irrevocable bought 57,000 shares of Rockwell Medical stock in a transaction dated Thursday, April 10th. The stock was bought at an average cost of $1.07 per share, for a total transaction of $60,990.
00. Following the purchase, the insider now owns 3,527,000 shares of the company’s stock, valued at $3,773,890. The trade was a 1.
64 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink . Insiders sold a total of 10,680 shares of company stock worth $11,552 over the last ninety days.
1.90% of the stock is currently owned by corporate insiders. Analyst Ratings Changes Separately, HC Wainwright decreased their price objective on Rockwell Medical from $7.
00 to $3.00 and set a “buy” rating for the company in a report on Monday, March 24th. Get Our Latest Stock Analysis on RMTI Rockwell Medical Profile ( Free Report ) Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide.
The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. Further Reading Want to see what other hedge funds are holding RMTI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rockwell Medical, Inc.
( NASDAQ:RMTI – Free Report ). Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter .
.
